Literature DB >> 32339611

Mitochondria in Alzheimer's disease and their potential role in Alzheimer's proteostasis.

Ian W Weidling1, Russell H Swerdlow2.   

Abstract

Alzheimer's disease (AD) is a progressive brain disorder characterized by memory loss and the accumulation of two insoluble protein aggregates, tau neurofibrillary tangles and beta-amyloid plaques. Widespread mitochondrial dysfunction also occurs and mitochondria from AD patients display changes in number, ultrastructure, and enzyme activities. Mitochondrial dysfunction in AD presumably links in some way to its other disease characteristics, either as a cause or consequence. This review characterizes AD-associated mitochondrial perturbations and considers their position in its pathologic hierarchy. It focuses on the crosstalk that occurs between mitochondria, nuclear gene expression, and cytosolic signaling pathways that serves to maintain cell homeostasis. To this point, recent evidence indicates mitochondria trigger retrograde responses that influence cell proteostasis in general and AD proteostasis specifically. Potentially pertinent retrograde responses include the mitochondrial unfolded protein response (mtUPR), integrated stress response (ISR), autophagy/mitophagy, and proteasome function. A fuller perspective of mitochondrial dysfunction in AD, and its relation to protein aggregation, could enhance our overall understanding of this disease.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aggregation; Alzheimer's disease; Metabolism; Mitochondria; Mitochondrial DNA; Mitophagy; Proteostasis

Mesh:

Year:  2020        PMID: 32339611      PMCID: PMC7282957          DOI: 10.1016/j.expneurol.2020.113321

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  129 in total

1.  Irregular distribution of cytochrome c oxidase protein subunits in aging and Alzheimer's disease.

Authors:  J Ojaimi; C L Masters; C McLean; K Opeskin; P McKelvie; E Byrne
Journal:  Ann Neurol       Date:  1999-10       Impact factor: 10.422

Review 2.  The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives.

Authors:  Russell H Swerdlow; Jeffrey M Burns; Shaharyar M Khan
Journal:  Biochim Biophys Acta       Date:  2013-09-23

Review 3.  Abnormalities of mitochondrial enzymes in Alzheimer disease.

Authors:  G E Gibson; K F Sheu; J P Blass
Journal:  J Neural Transm (Vienna)       Date:  1998       Impact factor: 3.575

4.  The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy.

Authors:  Günter U Höglinger; Annie Lannuzel; Myriam Escobar Khondiker; Patrick P Michel; Charles Duyckaerts; Jean Féger; Pierre Champy; Annick Prigent; Fadia Medja; Anne Lombes; Wolfgang H Oertel; Merle Ruberg; Etienne C Hirsch
Journal:  J Neurochem       Date:  2005-08-10       Impact factor: 5.372

5.  Bioenergetic flux, mitochondrial mass and mitochondrial morphology dynamics in AD and MCI cybrid cell lines.

Authors:  Diana F Silva; J Eva Selfridge; Jianghua Lu; Lezi E; Nairita Roy; Lewis Hutfles; Jeffrey M Burns; Elias K Michaelis; ShiDu Yan; Sandra M Cardoso; Russell H Swerdlow
Journal:  Hum Mol Genet       Date:  2013-06-04       Impact factor: 6.150

Review 6.  Use of cytoplasmic hybrid cell lines for elucidating the role of mitochondrial dysfunction in Alzheimer's disease and Parkinson's disease.

Authors:  S S Ghosh; R H Swerdlow; S W Miller; B Sheeman; W D Parker; R E Davis
Journal:  Ann N Y Acad Sci       Date:  1999       Impact factor: 5.691

Review 7.  Mitochondria, Cybrids, Aging, and Alzheimer's Disease.

Authors:  R H Swerdlow; S Koppel; I Weidling; C Hayley; Y Ji; H M Wilkins
Journal:  Prog Mol Biol Transl Sci       Date:  2017-02-01       Impact factor: 3.622

8.  Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease.

Authors:  P Mecocci; U MacGarvey; M F Beal
Journal:  Ann Neurol       Date:  1994-11       Impact factor: 10.422

9.  Aggresomes: a cellular response to misfolded proteins.

Authors:  J A Johnston; C L Ward; R R Kopito
Journal:  J Cell Biol       Date:  1998-12-28       Impact factor: 10.539

10.  Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study.

Authors:  Vijay R Varma; Anup M Oommen; Sudhir Varma; Ramon Casanova; Yang An; Ryan M Andrews; Richard O'Brien; Olga Pletnikova; Juan C Troncoso; Jon Toledo; Rebecca Baillie; Matthias Arnold; Gabi Kastenmueller; Kwangsik Nho; P Murali Doraiswamy; Andrew J Saykin; Rima Kaddurah-Daouk; Cristina Legido-Quigley; Madhav Thambisetty
Journal:  PLoS Med       Date:  2018-01-25       Impact factor: 11.069

View more
  23 in total

Review 1.  Deregulated mitochondrial microRNAs in Alzheimer's disease: Focus on synapse and mitochondria.

Authors:  Prashanth Gowda; P Hemachandra Reddy; Subodh Kumar
Journal:  Ageing Res Rev       Date:  2021-11-20       Impact factor: 10.895

2.  Tau phosphorylation and OPA1 proteolysis are unrelated events: Implications for Alzheimer's Disease.

Authors:  Marcel V Alavi
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2021-08-13       Impact factor: 4.739

3.  Mitochondrial Toxicity of Organic Arsenicals.

Authors:  Yu-Jiao Liu; Yi Liu
Journal:  Methods Mol Biol       Date:  2022

4.  Differential Gene Expression in Sporadic and Genetic Forms of Alzheimer's Disease and Frontotemporal Dementia in Brain Tissue and Lymphoblastoid Cell Lines.

Authors:  Oscar Ramos-Campoy; Albert Lladó; Beatriz Bosch; Mireia Ferrer; Agnès Pérez-Millan; Miguel Vergara; Laura Molina-Porcel; Laura Fort-Aznar; Ricardo Gonzalo; Fermín Moreno-Izco; Guadalupe Fernandez-Villullas; Mircea Balasa; Raquel Sánchez-Valle; Anna Antonell
Journal:  Mol Neurobiol       Date:  2022-08-12       Impact factor: 5.682

Review 5.  Altered Metabolism in Alzheimer Disease Brain: Role of Oxidative Stress.

Authors:  Nicole G Rummel; D Allan Butterfield
Journal:  Antioxid Redox Signal       Date:  2021-12-21       Impact factor: 7.468

Review 6.  Metabolic Mechanisms Connecting Alzheimer's and Parkinson's Diseases: Potential Avenues for Novel Therapeutic Approaches.

Authors:  Jerry R Colca; Brian N Finck
Journal:  Front Mol Biosci       Date:  2022-06-16

Review 7.  mTOR in Alzheimer disease and its earlier stages: Links to oxidative damage in the progression of this dementing disorder.

Authors:  M Perluigi; F Di Domenico; E Barone; D A Butterfield
Journal:  Free Radic Biol Med       Date:  2021-04-30       Impact factor: 8.101

Review 8.  Mitochondrial function in development and disease.

Authors:  Marlies P Rossmann; Sonia M Dubois; Suneet Agarwal; Leonard I Zon
Journal:  Dis Model Mech       Date:  2021-06-11       Impact factor: 5.758

Review 9.  Presenilin-2 and Calcium Handling: Molecules, Organelles, Cells and Brain Networks.

Authors:  Paola Pizzo; Emy Basso; Riccardo Filadi; Elisa Greotti; Alessandro Leparulo; Diana Pendin; Nelly Redolfi; Michela Rossini; Nicola Vajente; Tullio Pozzan; Cristina Fasolato
Journal:  Cells       Date:  2020-09-25       Impact factor: 6.600

Review 10.  SUMOylation-Mediated Response to Mitochondrial Stress.

Authors:  Jianli He; Jinke Cheng; Tianshi Wang
Journal:  Int J Mol Sci       Date:  2020-08-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.